• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Parkinson's Disease

Non-Invasive URIS® Device from Stimvia Delivers Promising Results for Parkinson’s Symptoms

by Fred Pennic 08/20/2025 Leave a Comment

Non-Invasive URIS® Device from Stimvia Delivers Promising Results for Parkinson's Symptoms

What You Should Know:  - Stimvia, a Czech medtech company, has successfully completed a clinical study on its URIS® device for the treatment of Parkinson’s disease symptoms.  - The study, which was published in the medical journal Clinical Parkinsonism & Related Disorders, confirms the safety of the non-invasive treatment and indicates a positive impact on both symptom relief and patients’ quality of life. Impact of Parkinson's Disease Parkinson's disease, the second
Read More

OM1 Launches Parkinson’s Disease Real-World Datasets for Neuroscience

by Jasmine Pennic 09/07/2023 Leave a Comment

OM1 Launches Parkinson’s Disease Real-World Datasets for Neuroscience

What You Should Know: Today, OM1 announced the launch of its Parkinson’s Disease datasets, enhancing its Mental Health & Neuroscience Real-World Data Network.OM1’s Mental Health & Neuroscience Real-World Data Network, which already includes robust datasets focused on Major Depressive Disorder, Multiple Sclerosis, Bipolar Disorder I and Schizophrenia, will further expand to include Alzheimer’s Disease in the coming months. Parkinson’s Disease Premium Dataset Nearly
Read More

The Case for Incorporating Patient Perspectives into Clinical Decision Support

by Greg Samios, President & CEO of Clinical Effectiveness, Wolters Kluwer, Health 10/17/2022 Leave a Comment

The Case for Incorporating Patient Perspectives into Clinical Decision Support

A recent report from the Leapfrog Group found that patient experience scores at hospitals declined during the pandemic. This should be no surprise. Hospitals faced an incredible crucible during COVID-19, with many still experiencing high levels of stress in their systems. In addition to increasing demands on caregivers, the pandemic created a fundamental change in how patients are treated. The drive to telehealth was rapidly accelerated,  transforming traditional in-person interactions between
Read More

PreciseDx’s AI-Enabled Digital Pathology Proven to Detect Early-Stage Parkinson’s Disease

by Jasmine Pennic 04/20/2022 Leave a Comment

PreciseDx's AI-Enabled Digital Pathology Proven to Detect Early-Stage Parkinson's Disease

What You Should Know: - Mount Sinai spinout, PreciseDx, today announced that its AI-enabled digital pathology is the first proven to detect early-stage Parkinson’s disease, according to a recent research study. - The study, conducted in collaboration with Michael J. Fox Foundation, identified that PreciseDx’s technology can accurately diagnose Parkinson's disease in living patients prior to the severe onset of symptoms. Challenges Diagnosing Parkinson’s
Read More

Medtronic Launches FDA-Approved Deep Brain Stimulation Device in U.S.

by Fred Pennic 10/31/2019 Leave a Comment

Medtronic Launches FDA-Approved Deep Brain Stimulation Device in U.S.

- Samsung and Medtronic unveils new state of the art FDA-approved Deep Brain Stimulation (DBS) device that uses a surgically implanted medical stimulator to deliver electric pulses directly to the brain.- Rather than using a bulky medical device, the Medtronic DBS solution allows patients to manage their therapy more discreetly and actually can reduce the need for regular doctor visits through more streamlined coordination directly with clinicians.Medtronic announced the U.S. launch of its
Read More

Alphabet and Michael J. Fox Foundation Team Up to Use Verily Study Watch to Research Parkinson’s Disease

by Fred Pennic 05/09/2018 Leave a Comment

Michael J. Fox Foundation Uses Verily Study Watch to Research Parkinson's

The Michael J. Fox Foundation for Parkinson's Research (MJFF) and Verily Life Sciences LLC, an Alphabet company has announced a new collaboration on a two-year sub-study in Parkinson's Progression Markers Initiative will include Verily Study Watch to add new dimension of health data. More than 800 participants will be equipped with Verily's multi-sensor investigational wearable device, to passively collect data on movement and physiologic and environmental measures continuously. The goal is to
Read More

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |